SlideShare uma empresa Scribd logo
1 de 43
Baixar para ler offline
Dierengezondheidszorg Vlaanderen vzw
1
Dealing with BRD in Flemish
veal calf production
Dr. Koen De Bleecker
Dierengezondheidszorg Vlaanderen vzw
2
1. Introduction
2. Situating the problem
3. Evaluating the BRD-
complex
4. Strategic approach
Content
3
Veal industry
4
• Small market: +/- 290.000 slaughtered calves
on 1100 herds
• 95% in Flanders
• 70% in the northern part (province of Antwerp)
• Strongly integrated (>90%)
• France (32%)> Netherlands (24%)> Belgium
(7%)
Veal calf production -Flanders
5
• 14 days on arrival – from different farms
• 3 breeds: dairy calves( 60%), Belgian Blue-
calves(20%)and mixed breeds(20%)
• Individual untill 6 weeks after arrival, then
groupe housing
• Slaughtered at 8 months (250kg)
• Nutrition
‐ mainly milk powder
‐ feed rich in fiber: 50 g to 250g at 20
weeks
• Production of white veal meat → ‘controlled’
anemia
Veal calves
6
• Grown within ‘VEEPEILER’
‐ Veepeiler= Monitoring program for cattle diseases
• Financed by Belgian Sanitary Fund= farmers money!!
• Main Purpose: monitoring infectious diseases in cattle: both
existing and emerging
• Means:
‐ Consultancy and advice for individual farms with specific problems:
» guidance
» extra analyses
» follow-up
‐ Shorttime projects with focus on practical and current topics:
» Veal calf BRD project
Situating the project
7
 1/. Situate the problem: mortality/morbidity figures
 2/. Evaluate the BRD complex in the veal calf
industry
identify the pathogens
 evaluate immunity
 evaluate environmental factors
 3/. Strategic approach of BRD in the veal calf
industry
Veal calf BRD project: aims & goals
8
• Gather figures on mortality/morbidity:
‐ 15 herds (5837 calves)
• 5 HF – herds (2743 calves)
• 5 Belgian Blue – herds (1487 calves)
• 5 mixed breed – herds (1607 calves)
‐ between oct 2007- oct 2009
1/ Situate the problem
‘‘Measurement is the first step that leads to control and eventually to
improvement. If you can’t measure something, you can’t understand it. If
you can’t understand it, you can’t control it. If you can’t control it, you can’t
improve it.’’
H. James Harrington
Pneumonia border line the most important cause of mortality  
Peritonitis/polyserositis and acute ruminitis important 
Average mortality= 5,17% (127/2458)
Dairy 4,38  % 
Mixed breed 4,76   %
Belgian Blue 7,43   %
9
Global mortality
Global mortality
2 peaks of mortality caused by pneumonia: 
week 4‐8 (acute disease) and week 17‐23 (mainly loss due to chronic pneumonia) 10
1 large peritonitis peak: week 8‐11
Polyserositis/peritonitis peak immediatly after a pneumonia peak
11
Global mortality
Peritonitis/polyserositis in veal calves
Exsudative fibrinous peritonitis
often with pneumonia, sometimes pleuritis
Several agents have been cultured:
Pasteurella, Mannheimia, E. coli, Klebsiella,…
Etiology?
Hematogenous?
Primary source:
• lung?
• abomasum?
Catry et al., 2005 J Clin Microbiol.43(3):1480-3
12
• Belgian Blue (7.43%)>> crossbreeds (4.76%) > dairy breed (4.38%)
• Pneumonia of greater importance in the Belgian Blue and crossbreed
• Belgian Blue: enterotoxaemia, arthritis, necrobacillosis
• Dairy breed: omphalitis and perforating abomasal ulcers 
• All breeds: polyserositis/peritonitis, acute ruminitis and diarrhea
13
Global morbidity
19.44% individually treated (478/2458 calves at risk) 
Pneumonia most important reason for individual treatment  
Diarrhea, otitis externa/media, peritonitis/polyserositis and arthritis important  •14
Pneumonia peak: week 2‐5 (climax week 5) (age: 24‐49 days)
Diarrhea: week 1‐3
Peritonitis/polyserositis: week 7‐11
2e half: limited amount of individual treatment 
15
Dairy 17.12  % 
Mixed 
breed 21.73   %
Belgian 
Blue 21.62   %
• Pneumonia: more treatment in Belgian Blue
(expensive calves‐farmer influence?‐ increased susceptibility pneumonia) 
• Belgian Blue: necrobacillosis, arthritis (also mixed breed)
• Otitis: dairy and mixed 
• Peritonitis: dairy 
16
Pneumonia on all farms the most important reason for treatment, but large variation 
Farm related: peritonitis, otitis, arthritis, omphalitis
True differences or ‘farmers nature’?
17
Morbidity parameters
farm 1 HF farm 2 HF farm 7 HF 
farm 3 
BBxHF 
farm 5 
BBxHF 
farm 4 
BWB 
farm 6 
BWB  average 
SARGEANT 
ET AL. **
Percentage individually treated 15,72    27,31    13,77    25,81    16.67 21,84    20.35 20.35
59,1 
(46‐78,5) 
Number of treatment days  941 238,00 222,00 115,00    70,00    394,00    334.43    334.43    ‐
Number of treatment days per 
treated calf 7.23    3.35 3.64    2,40    2,80    5,71    6.12 4.46   
5,6
(4,5‐10,6) 
Number of treatment days per 
calf 1,14    0.91 0,50    0,62    0,47    1,25    1.31    0.89   
3,3
(3,1‐8,2) 
* * Sargeant et al., 1994, Canadian Journal of Veterinary Research 58, 189‐195
In Belgium less individual treatments  compared to Canada
Major farm differences
Number of individual treatments: high on both Belgian blues
Adequate individual therapy length, but not always on consecutive days
But substantial amount of group treatments 18
Group treatments
42 group treatments for 6 farms: average= 7 (4‐12)
BRD most important reason for group treatment 
* Data on 6 farms (farm 4 excluded)
Conclusions
• Mortality and morbidity: Belgian Blue > crossbreed > dairy
• Pneumonia
– at very young age: 24-49 days (week 2-5 after arrival)
– more problems in the Belgian Blue breed
– all farms, large variation
• Peritonitis/polyserositis
– farm related
– all breeds: differences in clinical presentation between dairy
and Belgian Blue
• Acute ruminitis
– all farms, large variation between farms 20
Conclusions
• Breed predisposition
– Belgian Blue: arthritis, necrobacillosis, pneumonia,
enterotoxaemia
– dairy breed: peritonitis/polyserositis, perforating abomasal
ulcers
• Farm related prevalence
– peritonitis/polyserositis, otitis, arthritis, omphalitis,
pneumonia, diarrhea, acute ruminitis
• Antibiotic use
– extensive!! (group >> individual)
21
22
• Multifactorial
• Complex interaction of different factors
(animal-environment-pathogens)
• Tendency to overestimate the importance of
the pathogens involved!
2/ Evaluate the BRD-complex
Multifactorial model
Environ-
ment
Animal
Pathogens
BRD• Breed
• FPT ( colostrum)
• Oppressed
immunity (BVDV)
• Malnutrition
• Se-status
• Vaccinations
• Stress
• Ventilation and
climate
• Population density
• Hygiëne
• Herd management
• Humidity
• Dust
• Irritating gasses
• Viruses
• Bacteria
• Parasites
Identify the pathogens
I
d
e
n
t
i
f
y
Sampling 24 BRD-
’outbreaks’(okt. 07- Jan. 09)
-1.serumsamples of 10
calves: Ab BRD-virussen
and Mycoplasma bovis
-2.deep nasopharyngeal
swabs
-3.post mortems
Bacteria: calf level
Mycoplasma strongly present on calf level
32.7% of the calves: mixed infections
• 32.9% calves seroconverted clearly for M. bovis during
BRD-outbreak (63.2% showing increasing Ab- titer)
• Presence of Mycoplasma bovis during peak of BRD-
problems on 23/24 outbreaks
• M. haemolytica en P. multocida 70.8% each of the
outbreaks
• All three major bacterial pathogens found in 59.1% of the
outbreaks
Mycoplasma bovis
Antibiotics resistance
A lot of antibiotics frequently used orally seem to work inadequately
against the common pathogens
• BVD most found in serovonversions
• Mixed viral infections are seldom (5,6%) BVD frequently
found in those mixed infections
Viruses: calf level
Still BVD most present, followed by parainfluenza
IBR and bRSV seems to be less important
Viruses: herd level
• Outburst peak around 6.5 weeks after arrival (1-12.5 weken)
• 28.5% of the lungs = typical lesions for Mycoplasma bovis
• Mycoplasma bovis isolated in 61.9% of the lungs
• 33%: A. pyogenes ( suppurating bacteria)
• Mannheimia en Pasteurella found only sporadical
• 60% of the calves: BVD virus positive
• 20% of the calves: RSV positive
Post mortem
33
• What do we know so far?
‐ A lot of information!
‐ Problems that were found: frequent therapy failure!
• High presence of Mycoplasma bovis: few specific
treatments
• High presence of BVDV
• ‘Common’ BRD bacteria resistant to frequently used
antibiotics
‐ Too many different types of antibiotics on herd and on calf level!
‐ Insufficient in duration
‐ Insufficient in indication
3/ Strategic approach of BRD
34
• What is failure of therapy?
‐ Not working of a treatment = relapsing calves
• Evaluation of one of the outburst:
3/ Strategic approach of BRD
40/182 (22%) calves were individual
treated
72,2% single treatment (11% long
shot)
27,8% two or three days treatment
same antibiotic: 20%
different antibiotics: 80%
1e treatment Amount of calves
(% of treated
animals)
Lincospectin +
Neopen
57.6%
Danofloxacine 15.3%
Cefquinome 7.7%
Tulathromycine 7.7%
Florfenicol +
marbofloxine
3.8%
Marbofloxacine 3.8%
Tilmicosine 3.8%
35
• In conclusion of this outburst
3/ Strategic approach of BRD
Product Amount of days
Amoxycillin +
Colistin
6
Doxycyclin 5
Oxytetracyclin 10
Oxytetracyclin +
Tylosin
10
• 24% of the doses go to calves that
finally die!!!
• 29% of the doses given to 3 calves !!!(1
BVD positive, died)
• Group treatments
Amount of treatmentdays /treated calf:
5 days (individual) + 31 days= 36 days
Product Nb of given doses
Lincospectin 41
Neopen 43
Gentaject 1
Advocin 27
Nuflor 14
Cobactan 9
Vetalgin 3
Vetodexin 28
Meflosyl 9
Micotil 10
Metacam 3
Floxadyl 3
Emdofluxim 6
Draxxin 6
Marbocyl 5
Dicural 1
Multivit. 1
Potencil 2
212
36
• What can we change in treatments?
‐ Treat quickly
‐ Treat long enough
‐ Treat with broad-spectrum
• Won’t this increase labour for the farmer?
‐ NO:
• Less relapsing calves, less treatments
• Use longacting one-shot products!
3/ Strategic approach of BRD
SCORE 0 1 2 3
Rectal t°C
(°C)
< 38.5 38.5-39.0 39.0-39.5 > 39.5
Cough None Induced single cough Induced repeated cough
or occasional
spontaneous cough
Repeated
spontaneous cough
Nasal
discharge
Normal, serous Limited quantities of
unilateral ‘cloud’
colored discharge
Bilateral ‘cloud’ of
excessive muceus
discharge
Abundant bilateral
and purulent
Awareness Normal Slower, but responding
to stimulus
Isolated,responding
slowly to stimulus, lying
down a lot
Strongly reduced,
few responding to
stimulus
37
Decision making on treating or not: 
Score chart (McGuirk) 
38
• When do we treat an animal?
‐ Temp: 40°C → 3
‐ Spontaneous cough → 2
‐ Nasal discharge ‘cloud’ → 1
‐ Eyes → 0
‐ Moderate drooping ears → 1
‐ Total = 7
3/ Strategic approach of BRD
When score> 5 = treatment
With the thermometer in hand…
39
S h f t l
40
3/ Strategic approach of BRD
Decision of first treatment:
Score chart
Long shot or 7 days
Therapy succes
Failure of therapy:
daily antibiotics
for 1 week
Therapy failure:
Moving to sick-
bay
Euthanasia?
BVD‐antigen test?
3e treatment round?
*B. Pardon
Fac. Vet.Med.
Ghent University
41
• Why moving to a sick-bay?
‐ Chronically ill or relapsing calves: big shedders of
infection!
• BVD carrier
• chronically Mycoplasma infected
‐ ‘Sick-bay’: as far as possible from healthy calves
3/ Strategical approach of BRD
42
• Last but not least
‐ we know that:
• calves arriving from different herds : a lot of different
pathogens!
• some pathogens (Mycoplasma!) survive in wet and
chilly stable conditions
‐ key words between 2 rounds of calves:
• 1/ cleaning
• 2/ desinfecting
• 3/ sanitary void and drying!
3/ Strategical approach of BRD
43
43
Thank you for your attention!
Any questions?

Mais conteúdo relacionado

Mais procurados

Foot-and-mouth disease: Control and vaccination
Foot-and-mouth disease: Control and vaccinationFoot-and-mouth disease: Control and vaccination
Foot-and-mouth disease: Control and vaccinationILRI
 
Avian Mycoplasmosis Vaccination
Avian Mycoplasmosis VaccinationAvian Mycoplasmosis Vaccination
Avian Mycoplasmosis VaccinationOssama Motawae
 
Foot-and -Mouth Disease vaccines (B. Charleston)
Foot-and -Mouth Disease vaccines (B. Charleston)Foot-and -Mouth Disease vaccines (B. Charleston)
Foot-and -Mouth Disease vaccines (B. Charleston)EuFMD
 
Clostridia_Historical_Overview
Clostridia_Historical_OverviewClostridia_Historical_Overview
Clostridia_Historical_OverviewOssama Motawae
 
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and Limitations
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and LimitationsDr. James A. Roth - FMD Vaccination: Preparedness, Availability, and Limitations
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and LimitationsJohn Blue
 
Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...ILRI
 
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...Rafael Monleon
 
Diseases Among Layers & Broilers in India - Knowledge Day 2016
Diseases Among Layers & Broilers in India - Knowledge Day 2016Diseases Among Layers & Broilers in India - Knowledge Day 2016
Diseases Among Layers & Broilers in India - Knowledge Day 2016Poultry India
 
LIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualLIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualCharlotte Litten
 
Parasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in UseParasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in Usedranjansarma
 

Mais procurados (20)

Foot-and-mouth disease: Control and vaccination
Foot-and-mouth disease: Control and vaccinationFoot-and-mouth disease: Control and vaccination
Foot-and-mouth disease: Control and vaccination
 
Avian Mycoplasmosis Vaccination
Avian Mycoplasmosis VaccinationAvian Mycoplasmosis Vaccination
Avian Mycoplasmosis Vaccination
 
Foot and Mouth Disese control strategies
Foot and Mouth Disese control strategiesFoot and Mouth Disese control strategies
Foot and Mouth Disese control strategies
 
Foot-and -Mouth Disease vaccines (B. Charleston)
Foot-and -Mouth Disease vaccines (B. Charleston)Foot-and -Mouth Disease vaccines (B. Charleston)
Foot-and -Mouth Disease vaccines (B. Charleston)
 
Clostridia_Historical_Overview
Clostridia_Historical_OverviewClostridia_Historical_Overview
Clostridia_Historical_Overview
 
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and Limitations
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and LimitationsDr. James A. Roth - FMD Vaccination: Preparedness, Availability, and Limitations
Dr. James A. Roth - FMD Vaccination: Preparedness, Availability, and Limitations
 
Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...
 
Newer vaccine
Newer vaccineNewer vaccine
Newer vaccine
 
Hiv Vaccines Overview
Hiv Vaccines OverviewHiv Vaccines Overview
Hiv Vaccines Overview
 
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...
The Occurrence, Diagnosis and Control of Variant Infectious Bronchitis (a cor...
 
IBD_The Virus
IBD_The VirusIBD_The Virus
IBD_The Virus
 
IBD_Vaccination
IBD_VaccinationIBD_Vaccination
IBD_Vaccination
 
Vaccines 1
Vaccines  1Vaccines  1
Vaccines 1
 
Diseases Among Layers & Broilers in India - Knowledge Day 2016
Diseases Among Layers & Broilers in India - Knowledge Day 2016Diseases Among Layers & Broilers in India - Knowledge Day 2016
Diseases Among Layers & Broilers in India - Knowledge Day 2016
 
HUMAN IMMUNODEFICIENCY VIRUS/HIV
HUMAN IMMUNODEFICIENCY VIRUS/HIVHUMAN IMMUNODEFICIENCY VIRUS/HIV
HUMAN IMMUNODEFICIENCY VIRUS/HIV
 
LIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualLIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actual
 
Vaccine Safety Update
Vaccine Safety UpdateVaccine Safety Update
Vaccine Safety Update
 
Vaccine
VaccineVaccine
Vaccine
 
Parasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in UseParasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in Use
 
Fish Vaccination
Fish Vaccination Fish Vaccination
Fish Vaccination
 

Destaque

Angel Drug House Middle East
Angel Drug House Middle EastAngel Drug House Middle East
Angel Drug House Middle EastSylvia Dcosta
 
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...John Blue
 
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...TheVetRecruiter
 
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota Agriculture
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota AgricultureJoe Smentek - Recent Legislative and Regulatory Impacts on Minnesota Agriculture
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota AgricultureJohn Blue
 
Metabolic disorders in dairy animals
Metabolic disorders in dairy animalsMetabolic disorders in dairy animals
Metabolic disorders in dairy animalsrai khan
 
Antibiotics: classification and spectrum of action
Antibiotics: classification and spectrum of actionAntibiotics: classification and spectrum of action
Antibiotics: classification and spectrum of actionBashar Mudallal
 

Destaque (12)

Angel Drug House Middle East
Angel Drug House Middle EastAngel Drug House Middle East
Angel Drug House Middle East
 
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...
Dr. David R. Smith - What We know (and don’t know) About Pneumonia in Beef Ca...
 
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...
Reinventing Your Veterinary Career: Is Industry in Your Future (or Should It ...
 
Bovine
BovineBovine
Bovine
 
Calf diarrhoea
Calf diarrhoeaCalf diarrhoea
Calf diarrhoea
 
Bovine Viral Diarrhoea Virus
Bovine Viral Diarrhoea VirusBovine Viral Diarrhoea Virus
Bovine Viral Diarrhoea Virus
 
Calf diseases 4
Calf diseases 4Calf diseases 4
Calf diseases 4
 
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota Agriculture
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota AgricultureJoe Smentek - Recent Legislative and Regulatory Impacts on Minnesota Agriculture
Joe Smentek - Recent Legislative and Regulatory Impacts on Minnesota Agriculture
 
Metabolic disorders in dairy animals
Metabolic disorders in dairy animalsMetabolic disorders in dairy animals
Metabolic disorders in dairy animals
 
Bovine diseases
Bovine diseasesBovine diseases
Bovine diseases
 
Skeletal system of Bovine
Skeletal system of BovineSkeletal system of Bovine
Skeletal system of Bovine
 
Antibiotics: classification and spectrum of action
Antibiotics: classification and spectrum of actionAntibiotics: classification and spectrum of action
Antibiotics: classification and spectrum of action
 

Semelhante a 7.dealing with brd in flemish veal calf production

Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdf
Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdfCattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdf
Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdfMdAkhtaruzzamanSheik
 
Prevention and Control of Infectious Bronchitis in Asia
Prevention and Control of Infectious Bronchitis in AsiaPrevention and Control of Infectious Bronchitis in Asia
Prevention and Control of Infectious Bronchitis in AsiaRafael Monleon
 
03 vaccinationstrategieslast herin
03 vaccinationstrategieslast herin03 vaccinationstrategieslast herin
03 vaccinationstrategieslast herinMerial EMEA
 
pratima wagh Foot-and-mouth disease (FMD) .pptx
pratima wagh Foot-and-mouth disease (FMD) .pptxpratima wagh Foot-and-mouth disease (FMD) .pptx
pratima wagh Foot-and-mouth disease (FMD) .pptxPratimaWagh9
 
Measles elimination orig
Measles elimination origMeasles elimination orig
Measles elimination origSiva Mbbs
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAshokKp4
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAshokKp4
 
Prevention and Control of diseases transmitted through semen
Prevention and Control of diseases  transmitted through semenPrevention and Control of diseases  transmitted through semen
Prevention and Control of diseases transmitted through semenAswiniSivan
 
LATEST IAP GUIDELINES OF IMMUNISATION
LATEST IAP GUIDELINES OF IMMUNISATION LATEST IAP GUIDELINES OF IMMUNISATION
LATEST IAP GUIDELINES OF IMMUNISATION Dr Jishnu KR
 
Hepatitis viruses
Hepatitis virusesHepatitis viruses
Hepatitis virusesAlok Kumar
 
Emerging Pathogens
Emerging PathogensEmerging Pathogens
Emerging Pathogenssfyoder
 
Bovine Ephemeral Fever (Three Day Sickness)
Bovine Ephemeral Fever (Three Day Sickness)Bovine Ephemeral Fever (Three Day Sickness)
Bovine Ephemeral Fever (Three Day Sickness)Muhammad Avais
 
bordetella and brucella.ppt
bordetella and brucella.pptbordetella and brucella.ppt
bordetella and brucella.pptNCRIMS, Meerut
 
ICAWC 2012 : Paula Boyden Companion Animals in the EU
ICAWC 2012 : Paula Boyden Companion Animals in the EUICAWC 2012 : Paula Boyden Companion Animals in the EU
ICAWC 2012 : Paula Boyden Companion Animals in the EUDogs Trust
 
Healthy animals equals healthy, productive people
Healthy animals equals healthy, productive peopleHealthy animals equals healthy, productive people
Healthy animals equals healthy, productive peopleILRI
 

Semelhante a 7.dealing with brd in flemish veal calf production (20)

FMD.pdf
FMD.pdfFMD.pdf
FMD.pdf
 
Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdf
Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdfCattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdf
Cattle-Parasites-and-their-Control-Lecturers-PkA2015Final1.pdf
 
Prevention and Control of Infectious Bronchitis in Asia
Prevention and Control of Infectious Bronchitis in AsiaPrevention and Control of Infectious Bronchitis in Asia
Prevention and Control of Infectious Bronchitis in Asia
 
03 vaccinationstrategieslast herin
03 vaccinationstrategieslast herin03 vaccinationstrategieslast herin
03 vaccinationstrategieslast herin
 
pratima wagh Foot-and-mouth disease (FMD) .pptx
pratima wagh Foot-and-mouth disease (FMD) .pptxpratima wagh Foot-and-mouth disease (FMD) .pptx
pratima wagh Foot-and-mouth disease (FMD) .pptx
 
Necrotic Enteritis.pdf
Necrotic Enteritis.pdfNecrotic Enteritis.pdf
Necrotic Enteritis.pdf
 
Measles elimination orig
Measles elimination origMeasles elimination orig
Measles elimination orig
 
Dairy cattle
Dairy cattleDairy cattle
Dairy cattle
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .ppt
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .ppt
 
Prevention and Control of diseases transmitted through semen
Prevention and Control of diseases  transmitted through semenPrevention and Control of diseases  transmitted through semen
Prevention and Control of diseases transmitted through semen
 
LATEST IAP GUIDELINES OF IMMUNISATION
LATEST IAP GUIDELINES OF IMMUNISATION LATEST IAP GUIDELINES OF IMMUNISATION
LATEST IAP GUIDELINES OF IMMUNISATION
 
Hepatitis viruses
Hepatitis virusesHepatitis viruses
Hepatitis viruses
 
102906.pptx
102906.pptx102906.pptx
102906.pptx
 
Emerging Pathogens
Emerging PathogensEmerging Pathogens
Emerging Pathogens
 
MinimizingDrugUse
MinimizingDrugUseMinimizingDrugUse
MinimizingDrugUse
 
Bovine Ephemeral Fever (Three Day Sickness)
Bovine Ephemeral Fever (Three Day Sickness)Bovine Ephemeral Fever (Three Day Sickness)
Bovine Ephemeral Fever (Three Day Sickness)
 
bordetella and brucella.ppt
bordetella and brucella.pptbordetella and brucella.ppt
bordetella and brucella.ppt
 
ICAWC 2012 : Paula Boyden Companion Animals in the EU
ICAWC 2012 : Paula Boyden Companion Animals in the EUICAWC 2012 : Paula Boyden Companion Animals in the EU
ICAWC 2012 : Paula Boyden Companion Animals in the EU
 
Healthy animals equals healthy, productive people
Healthy animals equals healthy, productive peopleHealthy animals equals healthy, productive people
Healthy animals equals healthy, productive people
 

Mais de Merial EMEA

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialMerial EMEA
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigMerial EMEA
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Merial EMEA
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsMerial EMEA
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Merial EMEA
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationMerial EMEA
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaMerial EMEA
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonMerial EMEA
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Merial EMEA
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Merial EMEA
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyMerial EMEA
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Merial EMEA
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterMerial EMEA
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testMerial EMEA
 
ESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumMerial EMEA
 

Mais de Merial EMEA (20)

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - Merial
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - Merial
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - Merial
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculation
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparison
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
 
ESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL Momentum
 

Último

Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptxmary850239
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleCeline George
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptxmary850239
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsPooky Knightsmith
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDhatriParmar
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research DiscourseAnita GoswamiGiri
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
week 1 cookery 8 fourth - quarter .pptx
week 1 cookery 8  fourth  -  quarter .pptxweek 1 cookery 8  fourth  -  quarter .pptx
week 1 cookery 8 fourth - quarter .pptxJonalynLegaspi2
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 

Último (20)

Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP Module
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young minds
 
Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research Discourse
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
week 1 cookery 8 fourth - quarter .pptx
week 1 cookery 8  fourth  -  quarter .pptxweek 1 cookery 8  fourth  -  quarter .pptx
week 1 cookery 8 fourth - quarter .pptx
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of EngineeringFaculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 

7.dealing with brd in flemish veal calf production